Product Images Buprenorphine And Naloxone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Buprenorphine And Naloxone NDC 0378-8768 by Mylan Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Buprenorphine Hydrochloride Structural Formula - image 01

Buprenorphine Hydrochloride Structural Formula - image 01

Naloxone Hydrochloride Structural Formula - image 02

Naloxone Hydrochloride Structural Formula - image 02

Instructions for Use Figure 1 - image 03

Instructions for Use Figure 1 - image 03

Instructions for Use Figure 2 - image 04

Instructions for Use Figure 2 - image 04

Instructions for Use Figure 3 - image 05

Instructions for Use Figure 3 - image 05

Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg Carton Label - image 06

Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg Carton Label - image 06

This is a set of instructions and warning labels for using and storing Buprenorphine and Naloxone Sublingual Film. The package contains 20 sublingual films, each containing 2.16mg of buprenorphine HCI and 0.51mg of naloxone HCI. The films are placed under the tongue or inside the cheek and should not touch. It is advised to keep the package away from children and call emergency medical care if accidently taken by a child. The storage temperature should be at 20° to 25°C. The lot number and expiration date are also included.*

Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg Carton Label - image 07

Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg Carton Label - image 07

This is a description of instructions for properly taking Buprenorphine and Naloxone sublingual film, a medication used to treat opioid dependence. The text includes directions on how to administer the film under the tongue or inside the cheek as well as warnings to keep the medication out of reach of children and not to cut, chew or swallow the film. The medication should be stored at room temperature and each sublingual film contains 4.31mg of Buprenorphine HCI, equivalent to 4mg of Buprenorphine and 1.22mg of Naloxone HCI, equivalent to 1mg of Naloxone.*

Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg Carton Label - image 08

Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg Carton Label - image 08

This is a description of a medication called Buprenorphine and Naloxone Sublingual Film, which is designed for individuals suffering from opioid addiction. The medication is administered by placing the film under the tongue and letting it dissolve. The text also includes instructions for pharmacists regarding the dosage and storage of the product. Additionally, the text warns parents to keep the medication out of children's reach.*

Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg Carton Label - image 09

Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg Carton Label - image 09

This appears to be the label of Buprenorphine and Naloxone Sublingual Film, used for the treatment of opioid addiction. The label includes information about dosage, administration, and precautions, such as not cutting, chewing or swallowing the film. The label also includes a warning for accidental ingestion by children and lists equivalent doses of buprenorphine.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.